Home Tags Nasdaq:NBRV

Tag: Nasdaq:NBRV

Nabriva Therapeutics Granted New Technology Add-On Payment for XENLETA® (lefamulin) and CONTEPO™ (fosfomycin) by Centers for Medicare & Medicaid Services
Latest

Nabriva Therapeutics Granted New Technology Add-On Payment for XENLETA® (lefamulin) and CONTEPO™ (fosfomycin) by Centers for Medicare & Medicaid Services

Editor2 -
0
XENLETA® (lefamulin) Receives Health Canada Approval for Treatment of Community Acquired Pneumonia
Health

XENLETA® (lefamulin) Receives Health Canada Approval for Treatment of Community Acquired Pneumonia

Editor2 -
0
© Newspaper WordPress Theme by TagDiv